+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Sepsis Diagnostic Market Size, Share & Trends Analysis Report by Product (Instruments, Blood Culture Media, Assay Kits & Reagents, Software), by Technology, by Pathogen, by Testing Type, by Region, and Segment Forecasts, 2020 - 2027

  • ID: 4076547
  • Report
  • February 2020
  • Region: Global
  • 120 Pages
  • Grand View Research
1 of 4

FEATURED COMPANIES

  • Amara Health Analytics
  • bioMérieux SA
  • Cepheid
  • Danaher
  • GE Healthcare
  • Luminex Corporation
  • MORE
The global sepsis diagnostic market size is expected to reach a value of USD 1.1 billion by 2027, expanding at a CAGR of 9.4%. High prevalence of sepsis, introduction of technologically advanced medical examination systems and increasing government initiatives is expected to propel market growth over the forecast period.

According to CDC estimates, every year more than 1.7 million adults in the U.S. suffer from sepsis, which leads to around 270,000 deaths. Furthermore, according to the report published by OECD in 2018, every year around 3.8 million patients suffer from hospital-acquired infections (HAIs) in acute care hospitals in European countries. High prevalence of HAIs in key regions is expected to significantly increase the demand for medical examination solutions, thereby fueling market growth over the forecast period.

Increasing regulatory approval and introduction of technologically advanced medical examination solutions for the life-threatening disease condition are expected to facilitate market growth over the forecast period. In May 2018, T2 Biosystems, Inc., a the U.S.-based emerging medical examination solutions company received the U.S. FDA approval for its T2Bacteria Panel, intended for the detection of specific sepsis-causing bacterial pathogens in human whole blood specimens.

In April 2019, the Scottish Government in collaboration with Sepsis Research (originally called FEAT - The Fiona Elizabeth Agnew Trust) launched a Scotland-wide campaign to spread public awareness about the signs and symptoms of sepsis. Such initiatives to raise public awareness about the disease condition is expected to raise demand for its rapid medical examination solutions and support its market growth in the near future.

Further key findings from the study suggest:
  • In 2019, the blood culture media segment has emerged as the largest revenue generating segment owing to the high adoption of culture media tests in laboratories for the diagnosis of septic poisoning
  • Molecular diagnostics is anticipated to witness a lucrative CAGR over the forecast period owing to its high sensitivity, accuracy, and less turnaround time
  • In 2019, bacterial sepsis contributed towards the largest revenue share among the pathogen segment owing to its high prevalence
  • North America dominated the sepsis diagnostics market with the largest revenue share in 2019. High awareness, favorable reimbursement scenario, and presence of established players are facilitating the dominance of this region during the study period
  • The Asia Pacific region is projected to witness a lucrative growth owing to increasing awareness about sepsis diagnosis and treatment in emerging economies such as India and China
  • Some of the key players include bioMérieux SA, Beckman Coulter, Inc., Becton, Dickinson and Company, Sysmex Corporation, F. Hoffmann-La Roche AG, and Thermo Fisher Scientific, Inc.

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Amara Health Analytics
  • bioMérieux SA
  • Cepheid
  • Danaher
  • GE Healthcare
  • Luminex Corporation
  • MORE
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.3.1 Purchased database
1.3.2 internal database
1.3.3 Secondary sources & third party perspectives
1.3.4 Primary research
1.4 Information analysis
1.4.1 Data analysis models
1.5 Market formulation & data visualization
1.6 Data validation & publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Sepsis Diagnostics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market driver analysis
3.3.1.1 High prevalence of sepsis
3.3.1.2 Approval and launch of advance sepsis diagnostic systems
3.3.1.3 Government initatives to spread awarness about early sepsis diagnosis
3.3.1.4 Increasing R & D investments
3.3.1.5 Strategic initatives by major players
3.3.2 Market Restraint Analysis
3.3.2.1 High cost of products
3.3.2.2 Product recall
3.3.2.3 Stringent regulatory framework
3.3.3 Industry challenges
3.3.3.1 Pricing pressure
3.4 Sepsis Diagnostics Market Analysis Tools
3.4.1 Industry analysis - Porter’s
3.4.1.1 Supplier Power
3.4.1.2 Buyer Power
3.4.1.3 Substitution Threat
3.4.1.4 Threat from new entrants
3.4.1.5 Competitive Rivalry
3.4.2 PESTEL Analysis
3.4.2.1 Political Landscape
3.4.2.2 Environmental Landscape
3.4.2.3 Social landscape
3.4.2.4 Technology landscape
3.4.2.5 Legal Landscape
3.4.3 Major deals and strategic alliances analysis
3.4.3.1 Joint ventures
3.4.3.2 Mergers and acquisitions
3.4.3.3 Licensing and partnership
3.4.3.4 Technology collaborations
3.4.3.5 Strategic divestments
3.4.4 Market entry strategies

Chapter 4 Sepsis Diagnostics Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Vendor Landscape
4.2.1 List of key distributors and channel partners
4.2.2 Key company market share analysis, 2019
4.3 Public Companies
4.3.1 Company market position analysis
4.3.2 Competitive dashboard analysis
4.4 Private Companies
4.4.1 List of key emerging companies
4.4.2 Regional network map
4.4.3 Company market position analysis

Chapter 5 Sepsis Diagnostics Market: Product Estimates and Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2019 & 2027
5.3 Segment Dashboard
5.4 Global Sepsis Diagnostics Market, by Product, 2016 to 2027
5.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
5.5.1 Instruments
5.5.1.1 Instruments Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.1.2 Microbiology
5.5.1.2.1 Microbiology Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.1.3 Molecular Diagnostics
5.5.1.3.1 Molecular Diagnostics Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.1.4 Immunoassays
5.5.1.4.1 Immunoassays Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.1.5 Flow Cytometry
5.5.1.5.1 Flow Cytometry Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2 Blood Culture Media
5.5.2.1 Blood Culture Media Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2.2 Microbiology
5.5.2.2.1 Microbiology Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2.3 Molecular Diagnostics
5.5.2.3.1 Molecular Diagnostics Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2.4 Immunoassays
5.5.2.4.1 Immunoassays Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.2.5 Flow Cytometry
5.5.2.5.1 Flow Cytometry Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3 Assay Kits and Reagents
5.5.3.1 Assay Kits and Reagents Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.2 Microbiology
5.5.3.2.1 Microbiology Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.3 Molecular Diagnostics
5.5.3.3.1 Molecular Diagnostics Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.4 Immunoassays
5.5.3.4.1 Immunoassays Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.3.5 Flow Cytometry
5.5.3.5.1 Flow Cytometry Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.4 Software
5.5.4.1 Software Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.4.2 Microbiology
5.5.4.2.1 Microbiology Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.4.3 Molecular Diagnostics
5.5.4.3.1 Molecular Diagnostics Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.4.4 Immunoassays
5.5.4.4.1 Immunoassays Market Estimates and Forecasts, 2016 to 2027 (USD Million)
5.5.4.5 Flow Cytometry
5.5.4.5.1 Flow Cytometry Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 6 Sepsis Diagnostics Market: Technology Estimates and Trend Analysis
6.1 Definition & Scope
6.2 Technology Market Share Analysis, 2019 & 2027
6.3 Segment Dashboard
6.4 Global Sepsis Diagnostics Market, by Technology, 2016 to 2027
6.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
6.5.1 Microbiology
6.5.1.1 Microbiology Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.2 Molecular Diagnostics
6.5.2.1 Molecular Diagnostics Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.3 Immunoassays
6.5.3.1 Immunoassays Market Estimates and Forecasts, 2016 to 2027 (USD Million)
6.5.4 Flow Cytometry
6.5.4.1 Flow Cytometry Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 7 Sepsis Diagnostics Market: Pathogen Estimates and Trend Analysis
7.1 Definition & Scope
7.2 Testing Type Market Share Analysis, 2019 & 2027
7.3 Segment Dashboard
7.4 Global Sepsis Diagnostics Market, by Pathogen, 2016 to 2027
7.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
7.5.1 Bacterial Sepsis
7.5.1.1 Bacterial Sepsis Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.1.2 Gram-Positive Bacteria
7.5.1.2.1 Gram-Positive Bacteria Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.1.3 Gram-Negative Bacteria
7.5.1.3.1 Gram-Negative Bacteria Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.2 Fungal Sepsis
7.5.2.1 Fungal Sepsis Market Estimates and Forecasts, 2016 to 2027 (USD Million)
7.5.3 Others
7.5.3.1 Others Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 8 Sepsis Diagnostics Market: Testing Type Estimates and Trend Analysis
8.1 Definition & Scope
8.2 Testing Type Market Share Analysis, 2019 & 2027
8.3 Segment Dashboard
8.4 Global Sepsis Diagnostics Market, by Testing Type, 2016 to 2027
8.5 Market Size & Forecasts and Trend Analyses, 2016 to 2027
8.5.1 Laboratory Testing
8.5.1.1 Laboratory Testing Market Estimates and Forecasts, 2016 to 2027 (USD Million)
8.5.2 PoC Testing
8.5.2.1 PoC Testing Market Estimates and Forecasts, 2016 to 2027 (USD Million)

Chapter 9 Sepsis Diagnostics Market: Regional Estimates & Trend Analysis
9.1 Regional Market Snapshot
9.2 Regional Market Share and Leading Players, 2019
9.2.1 North America
9.2.2 Europe
9.2.3 Latin America
9.2.4 Asia Pacific
9.2.5 Middle East & Africa
9.3 Market Share Analysis by Country, 2019
9.3.1 North America
9.3.1.1 U.S.
9.3.1.2 Canada
9.3.2 Europe
9.3.2.1 U.K.
9.3.2.2 Germany
9.3.2.3 Spain
9.3.2.4 France
9.3.2.5 Italy
9.3.2.6 Russia
9.3.3 Latin America
9.3.3.1 Brazil
9.3.3.2 Mexico
9.3.3.3 Argentina
9.3.4 Asia Pacific
9.3.4.1 Japan
9.3.4.2 China
9.3.4.3 India
9.3.4.4 South Korea
9.3.4.5 Singapore
9.3.4.6 Australia
9.3.5 Middle East & Africa
9.3.5.1 South Africa
9.3.5.2 Saudi Arabia
9.3.5.3 UAE
9.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
9.4.1 North America
9.4.2 Europe
9.4.3 Latin America
9.4.4 Asia Pacific
9.4.5 Middle East & Africa
9.5 Market Size & Forecasts, and Trend Analysis, 2019 to 2027
9.5.1 North America
9.5.1.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.1.2 U.S.
9.5.1.2.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.1.2.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.1.2.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.1.2.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.1.3 Canada
9.5.1.3.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.1.3.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.1.3.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.1.3.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.2 Europe
9.5.2.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.2.2 U.K.
9.5.2.2.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.2.2.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.2.2.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.2.2.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.2.3 Germany
9.5.2.3.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.2.3.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.2.3.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.2.3.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.2.4 Spain
9.5.2.4.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.2.4.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.2.4.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.2.4.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.2.5 France
9.5.2.5.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.2.5.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.2.5.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.2.5.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.2.6 Italy
9.5.2.6.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.2.6.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.2.6.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.2.6.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.2.7 Russia
9.5.2.7.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.2.7.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.2.7.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.2.7.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.3 Latin America
9.5.3.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.3.2 Brazil
9.5.3.2.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.3.2.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.3.2.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.3.2.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.3.3 Mexico
9.5.3.3.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.3.3.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.3.3.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.3.3.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.3.4 Argentina
9.5.3.4.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.3.4.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.3.4.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.3.4.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.4 Asia Pacific
9.5.4.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.4.2 Japan
9.5.4.2.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.4.2.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.4.2.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.4.2.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.4.3 China
9.5.4.3.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.4.3.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.4.3.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.4.3.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.4.4 India
9.5.4.4.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.4.4.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.4.4.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.4.4.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.4.5 South Korea
9.5.4.5.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.4.5.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.4.5.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.4.5.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.4.6 Singapore
9.5.4.6.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.4.6.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.4.6.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.4.6.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.4.7 Australia
9.5.4.7.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.4.7.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.4.7.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.4.7.3 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.5 Middle East & Africa
9.5.5.1 Market Size & Forecasts and Trend Analysis, 2016 to 2027 (USD Million)
9.5.5.2 South Africa
9.5.5.2.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.5.2.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.5.2.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.5.2.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.5.3 Saudi Arabia
9.5.5.3.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.5.3.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.5.3.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.5.3.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)
9.5.5.4 UAE
9.5.5.4.1 Market Size & Forecasts and Trend Analysis, by Product, 2016 to 2027 (USD Million)
9.5.5.4.2 Market Size & Forecasts and Trend Analysis, by Technology, 2016 to 2027 (USD Million)
9.5.5.4.3 Market Size & Forecasts and Trend Analysis, by Pathogen, 2016 to 2027 (USD Million)
9.5.5.4.4 Market Size & Forecasts and Trend Analysis, by Testing Type, 2016 to 2027 (USD Million)

Chapter 10 Company Profile
10.1 Company Profiles
10.1.1 bioMérieux SA
10.1.1.1 Company overview
10.1.1.2 Financial Performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 Becton, Dickinson and Company (BD)
10.1.2.1 Company overview
10.1.2.2 Financial Performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 Sysmex Corporation
10.1.3.1 Company overview
10.1.3.2 Financial Performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 Thermo Fisher Scientific, Inc.
10.1.4.1 Company overview
10.1.4.2 Financial Performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 Roche Diagnostics
10.1.5.1 Company overview
10.1.5.2 Financial Performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 Danaher
10.1.6.1 Cepheid
10.1.6.1.1 Company overview
10.1.6.1.2 Financial Performance
10.1.6.1.3 Product benchmarking
10.1.6.1.4 Strategic initiatives
10.1.6.2 Beckman Coulter, Inc.
10.1.6.2.1 Company overview
10.1.6.2.2 Financial Performance
10.1.6.2.3 Product benchmarking
10.1.6.2.4 Strategic initiatives
10.1.7 Luminex Corporation
10.1.7.1 Company overview
10.1.7.2 Financial Performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 Bruker Corporation
10.1.8.1 Company overview
10.1.8.2 Financial Performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 Amara Health Analytics
10.1.9.1 Company overview
10.1.9.2 Financial Performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 Wolters Kluwer N.V.
10.1.10.1 Company overview
10.1.10.2 Financial Performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives
10.1.11 Cerner Corporation
10.1.11.1 Company overview
10.1.11.2 Financial Performance
10.1.11.3 Product benchmarking
10.1.11.4 Strategic initiatives
10.1.12 Epic Systems Corporation
10.1.12.1 Company overview
10.1.12.2 Financial Performance
10.1.12.3 Product benchmarking
10.1.12.4 Strategic initiatives
10.1.13 McKesson Corporation
10.1.13.1 Company overview
10.1.13.2 Financial Performance
10.1.13.3 Product benchmarking
10.1.13.4 Strategic initiatives
10.1.14 GE Healthcare
10.1.14.1 Company overview
10.1.14.2 Financial Performance
10.1.14.3 Product benchmarking
10.1.14.4 Strategic initiatives
10.1.15 Koninklijke Philips N.V.
10.1.15.1 Company overview
10.1.15.2 Financial Performance
10.1.15.3 Product benchmarking
10.1.15.4 Strategic initiatives


*Full List of Tables and Figures Available on Enquiry.
Note: Product cover images may vary from those shown
3 of 4
  • bioMérieux SA
  • Becton, Dickinson and Company (BD)
  • Sysmex Corporation
  • Thermo Fisher Scientific, Inc.
  • Roche Diagnostics
  • Danaher
  • Cepheid
  • Beckman Coulter, Inc.
  • Luminex Corporation
  • Bruker Corporation
  • Amara Health Analytics
  • Wolters Kluwer N.V.
  • Cerner Corporation
  • Epic Systems Corporation
  • McKesson Corporation
  • GE Healthcare
  • Koninklijke Philips N.V.
Note: Product cover images may vary from those shown
4 of 4

Loading
LOADING...

Adroll
adroll